PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsCryoglobulinemia
MeSH D003449 - cryoglobulinemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010265:Paraproteinemias
$
Success rate
D020141:Hemostatic disorders
$
Success rate
D017445:Vascular skin diseases
0 Companies
0 Drugs
Success rate
D003449: 
Cryoglobulinemia
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
RocheRibavirin, Peginterferon alfa-2a Pegasys Copegus  2004-06-04   
Merck & CoRibavirin, Peginterferon alfa-2b PegIntron/ Rebetol Combo Pack  2008-06-13   
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
38%
3/8
Phase 3
57%
4/7
Approved: 4Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use